text_1: Treatment with the EC uptake inhibitor AM404 resulted in a dose-dependent decrease in the expression of immobility.
text_2: Although AM404 did not activate cannabinoid receptors or inhibit anandamide hydrolysis, it enhanced receptor-mediated anandamide responses in vitro and in vivo.